Belumosudil (Rezurock)

Status:
Red
Decision Date:
September 2022
 

Comments

RED: NICE TA949 - Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over. NHSE commissioned. (Decision date - March 2024)

 


Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app